Recruiting NA INTERVENTIONAL 1-arm NCT05898594

Lung Cancer Screening in High-risk Black Individuals

Evaluating the Feasibility of Lung Cancer Screening in High-risk Black Individuals

Sponsor: Agency for Healthcare Research and Quality (AHRQ)

Interventions Low-dose Computed Tomography

Updated 7 times since 2023 Last updated: Feb 20, 2026 Started: Sep 6, 2023 Primary completion: Jun 30, 2028 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lung Cancer and Lung Carcinoma and is currently actively recruiting participants. Agency for Healthcare Research and Quality (AHRQ) leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA
Jan 2026 — Feb 2026 [monthly]

Recruiting NA
Dec 2024 — Jan 2026 [monthly]

Recruiting NA
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Nov 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2023 — Nov 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Agency for Healthcare Research and Quality (AHRQ)
Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States
• Chicago, United States